Filing Details
- Accession Number:
- 0001209191-19-021881
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-29 20:08:59
- Reporting Period:
- 2019-03-27
- Accepted Time:
- 2019-03-29 20:08:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1340652 | Chemocentryx Inc. | CCXI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226064 | M Susan Kanaya | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Evp, Cfo And Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-27 | 35,000 | $3.57 | 110,890 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-03-27 | 35,000 | $13.05 | 75,890 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-03-27 | 35,000 | $0.00 | 35,000 | $3.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
106,963 | 2026-03-07 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a March 2018 Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $13.00 to $13.24 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of March 27, 2019, and prior to this transaction, the exercised options were fully vested.
- Not applicable.